Neurobell develop novel products for early detection and monitoring of neonatal seizures to facilitate better treatment and patient outcomes.

NeuroBell

We are thrilled to announce that NeuroBell has spun out of UCC and raised €2.1m in seed funding.

The investment round, led by Furthr VC, Atlantic Bridge, HBAN, with participation from Enterprise Ireland and private investors, will allow us to bring our novel technology for seizure detection & EEG monitoring in newborns to market in 2025.

Sincere thanks to University College Cork and INFANT Research Centre for supporting the research and development of the technology, and to the whole NeuroBell team for making this possible.

Mark O'Sullivan Alison O'Shea Colm Murphy
#neurobell #medtech #newborncare 
https://lnkd.in/efPmX92v

Exciting night ahead at Clontarf Castle, Dublin as we are joined by Mark Simpson, our host of the #Seedcorn2023 All-island Final!

Finalists competed in the NI, Dublin, Connacht & Leinster, and Munster regional finals, to walk away with €20,000 each and the chance to compete in tonight’s overall final.

Going head-to-head in our Best New-Start category is Neurodiversity Training International, Brace, Omuu Petfood and Mavarick. While Ilimex Ltd, NeuroBell, Galenband and EVE will compete for the Best Early-Stage title.  

Good luck to all finalists and stay tuned as we announce our overall #Seedcorn2023 winner! 👏

Huge congratulations to Dr. Mark O'Sullivan, INFANT Lead Investigator and co-founder of NeuroBell, who was awarded the "Best Early Stage" Munster regional trophy at the InterTradeIreland Seedcorn Investor Readiness Munster regional final.

The winners were awarded €20,000 and will advance to the All-Island final in Dublin on the 9th of November. The InterTradeIreland Seedcorn Investor Readiness Competition is the largest business competition of its kind on the island of Ireland, Seedcorn has an overall prize fund of €300,000. 

NeuroBell has developed a novel medical device for early detection and monitoring of seizures in newborn infants. Dr. Mark O’Sullivan, Chief Executive of NeuroBell said:

"It is absolutely fantastic to win this award and it will greatly help us in progressing our plans for the business. The prize money will assist our research and development work to make our product globally scalable. As we are in the process of raising Seed Round investment with a view to launching in the US and across Europe, the competition has provided a great opportunity to refine and get feedback on our business plan."

https://lnkd.in/eDwJzF5n

Congratulations to Mavarick and NeuroBell who have won the awards for Best New Start and Best Early Stage, respectively, at our Seedcorn Munster Regional Final.

Leaving with a prize fund of €20,000, these innovative companies are gearing up for the #Seedcorn2023 final on 9th November.

Read more, here https://lnkd.in/edNDj_nS

We’re #hiring a new Embedded Systems Engineer in Cork, County Cork. Apply today or share this post with your network.

#engineering #electronics #firmware #medical #devices #healthcare

Omniscient Neurotechnology specializes in neurotechnology and is a competitor of NeuroBell in the development of brain-computer interface (BCI) systems.

Omniscient Neurotechnology

Synaptive Medical is a medical technology company that competes with NeuroBell in the development of advanced medical devices and technology for neurological conditions.

Synaptive Medical

Flywheel is a competitor of NeuroBell in the neurotechnology sector, focusing on developing advanced brain-computer interface (BCI) systems and assistive devices.

Flywheel

MindTrace is a competitor of NeuroBell in the development of neurotechnology and assistive devices, aiming to enhance the quality of life for individuals with neurological conditions.

MindTrace

Neurobell is a neurotechnology company that specializes in developing advanced brain-computer interface (BCI) systems designed to improve the quality of life for individuals with neurological conditions. Their technology focuses on decoding neural signals to enable communication and control for those with paralysis or other impairments.

Neurobell

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 11, 2024 7:59 AM	16082102
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 11, 2024 6:17 PM	487cb28a
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 11, 2024 7:59 AM	52d80f20
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 11, 2024 7:59 AM	cc479abf
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:NEUROBELL

Neurobell